0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Presidential Address | 
Ashby C. Moncure, MD
Arch Surg. 2001;136(4):376-382. doi:10.1001/archsurg.136.4.376.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
Annette Langer-Gould, MD, PhD; Lei Qian, PhD; Sara Y. Tartof, PhD; et al.
JAMA Neurology
Original Investigation  | 
Impaired Cerebrovascular Reactivity in Multiple Sclerosis
Olga Marshall, MS; Hanzhang Lu, PhD; Jean-Christophe Brisset, PhD; et al.
JAMA Neurology
Original Investigation  | 
The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis
Sara J. Ireland, BA; Alyssa A. Guzman, BS; Dina E. O’Brien, BS; et al.
JAMA Neurology
Editorial  | 
Mycophenolate Mofetil to Treat Neuromyelitis Optica:  Is It Time for a Randomized Trial?
Bruce Cree, MD, PhD, MAS